⌘K

Login Start Free

Home/Filings/4/0000875320-24-000202

4//SEC Filing

Bozic Carmen 4

Accession 0000875320-24-000202

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 4:06 PM ET

Size

4.7 KB

Accession

0000875320-24-000202

Insider Transaction Report

Form 4

Period: 2024-08-07

VERTEX PHARMACEUTICALS INC / MAVRTX

EVP and CMO

Transactions

Sale
Common Stock
2024-08-07$476.75/sh−2,280$1,086,990→ 23,259 total

Footnotes (1)

[F1]Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 02/27/2024.

Documents

1 file

4
wk-form4_1723147577.xmlPrimary
FORM 4

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001790029

Filing Metadata

Form type: 4
Filed: Aug 7, 8:00 PM ET
Accepted: Aug 8, 4:06 PM ET
Size: 4.7 KB

View on SEC.gov